QTREX Quantum Ltd.
QTEXNasdaq
$1.27
↓ -5.2%Jul 17 close · end-of-day
Price
1Y↓ -7.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$37.6M
Enterprise Value
$34.5M
P/E
—
P/S
130.2
P/B
16.2
EV/EBITDA
—
PEG
—
FCF Yield
-26.5%
Dividend Yield
—
Revenue (TTM)
$289,000.00
Net Income (TTM)
-$13.2M
Free Cash Flow (TTM)
-$10.0M
Gross Margin
0.7%
Operating Margin
-4713.8%
Net Margin
-4574.4%
ROE
-569.1%
ROIC
—
Debt / Equity
—
Net Cash
$3.2M
Return 1Y
-13.6%
Company profile
Inspira Technologies Oxy B.H.N. Ltd. engages in the research, development, manufacture, and marketing of respiratory support technology. Its lead product is the augmented respiration technology system (ART) The company was formerly known as Insense Medical Ltd.
- CEO
- Dagi S. Ben-Noon
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 20
- Website
- inspira-technologies.com
Management & directors
- Rozanovich YoavChief Business Officer
- Tehila YafitChief Financial Officer
- Yechezkely Hayon DaniellaChief Technology Officer
- Shabtay AbrahamCOO and VP of R&D
Roles derived from SEC Form 4 filings.
Earnings
No reported earnings periods on file.
Financial statements
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $0.00 | $289,000.00 |
| Gross profit | — | — | $0.00 | $0.00 | $2,000.00 |
| Operating income | -$13.0M | -$14.9M | -$12.1M | -$11.3M | -$13.6M |
| Net income | -$17.2M | -$15.0M | -$11.3M | -$11.1M | -$13.2M |
| Diluted EPS | -$3.24 | -$1.39 | -$0.93 | -$0.60 | -$0.45 |
| Operating cash flow | -$6.7M | -$9.2M | -$9.7M | -$9.4M | -$9.9M |
| Free cash flow | -$6.9M | -$9.5M | -$9.9M | -$9.5M | -$10.0M |
| Gross margin | — | — | — | — | 0.7% |
| Operating margin | — | — | — | — | -4713.8% |
| Net margin | — | — | — | — | -4574.4% |
No quarterly data.
Company news
Jul 10, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-06 | Tehila Yafit· Chief Financial Officer | Award | 550,000 | $0.00 | $0.00 | filing |
| 2026-07-06 | Rozanovich Yoav· Chief Business Officer | Award | 550,000 | $0.00 | $0.00 | filing |
| 2026-07-06 | Yechezkely Hayon Daniella· Chief Technology Officer | Award | 550,000 | $0.00 | $0.00 | filing |
| 2026-07-06 | shabtay abraham· COO | Award | 550,000 | $0.00 | $0.00 | filing |
| 2026-06-01 | Tehila Yafit· Chief Financial Officer | Sale | 28,100 | $3.50 | $98,350.00 | filing |
| 2026-05-29 | shabtay abraham· COO and VP of R&D | Option exercise | 95,239 | $3.37 | $320,955.43 | filing |
| 2026-05-29 | Yechezkely Hayon Daniella· Chief Technology Officer | Sale | 50,000 | $3.00 | $150,000.00 | filing |
| 2026-05-29 | Tehila Yafit· Chief Financial Officer | Sale | 1,900 | $3.51 | $6,669.00 | filing |
| 2026-05-28 | Tehila Yafit· Chief Financial Officer | Sale | 15,000 | $3.00 | $45,000.00 | filing |
| 2026-05-28 | Tehila Yafit· Chief Financial Officer | Sale | 15,000 | $2.56 | $38,400.00 | filing |
| 2026-05-27 | Tehila Yafit· Chief Financial Officer | Sale | 16,395 | $2.01 | $33,009.69 | filing |
| 2026-05-27 | Tehila Yafit· Chief Financial Officer | Sale | 13,605 | $2.03 | $27,551.49 | filing |
| 2026-05-27 | Tehila Yafit· Chief Financial Officer | Option exercise | 13,605 | $0.12 | $1,632.60 | filing |
Latest 13 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.